Real-life efficacy and safety data of lorlatinib treatment in ROS-1–positive advanced non-small cell lung cancer: Turkish Oncology Group (TOG) study.

Authors: Sedat Biter, Ahmet Taner Sümbül, Serdar Karakaya, Orhun Akdogan, Ali Güren, Mehmet Cihan İcli̇, Mahmut Büyüksimsek, Engin Kut, Serkan Menekse, Serhat Sekmek, Ozde Melisa Celayir, Gizem Yıldırım, Mehmet Emin Kalender, Ferit Aslan, Hicran Anık, Sevgi Topcu, Hasan Çağrı Yıldırım, Salih Tunbekici, Umut Disel, Ismail Oguz Kara

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20659

Source: Full article

---

Abstract

e20659